High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab.
Edoardo ConticiniFederico FranchiDavid BennettSerafina ValenteMaria A MazzeiElena BargagliLuca VolterraniSabino ScollettaBruno FredianiPublished in: Annals of the rheumatic diseases (2020)